What is CRPN Quality Roadmap®?
There was a moment in my career as a regional VP of Quality responsible for several large production sites, 25 large contract manufacturers, and thousands of suppliers that I thought I would never figure out which five to ten CAPAs out of thousands were the highest priority for my region.
I sat on a large regional leadership board led by a regional Company Group Chairman who had asked me to present the top five priorities. We all understood risk management principles and tried to prioritize the thousands of CAPAs using a spreadsheet. However, we could not objectively prioritize and create a visual picture of our highest-risk priorities that was appropriate for a leadership board.
At that time, I met with John (Jack) Garvey, CEO of Compliance Architects, and told him I was suffering from “death by CAPA” when he opened our meeting by asking, “How are you?”.
Within two weeks, Jack and one of his colleagues returned and demonstrated a bespoke tool they had created to help my team objectively prioritize all the CAPAs across our region.
Enter stage left…. the CRPN Quality Roadmap®. This process and bespoke tool offered us a structured methodology designed to streamline risk assessment and enhance quality planning for our organization… for any Pharma, BioPharma, or Medical Device company.
Table of Contents
What is CRPN Quality Roadmap®?
So, what is CRPN Quality Roadmap®? The CRPN Quality Roadmap® is a “solution” developed by Compliance Architects®. It combines a defined methodology, proprietary risk and complexity algorithms, and a cloud-based software tool.
Together, these components enable life-science manufacturers to engage in intelligent, semi-quantitative, risk-based planning, ultimately leading to more effective quality outcomes.
At its core, the CRPN Quality Roadmap® aims to quantify FDA compliance risk and remediation/quality improvement complexity.
Providing a structured approach helps organizations assess risk more effectively and develop pragmatic and resource-conscious strategic and tactical quality plans.
A Proven Methodology
What sets the CRPN Quality Roadmap® apart is its proven methodology. This structured approach allows companies to assess, aggregate rapidly, and formally prioritize their risks, issues, and objectives based on risk and complexity considerations.
This means organizations can make informed decisions on resource allocation based on the relative risk rankings of various topics. Our video below goes into more detail about the CRPN Methodology.
The CRPN Quality Roadmap® has been embraced by some of the most respected companies in the life sciences sector. It has helped drive practical quality planning activities and facilitated strategic and tactical remediation/quality improvement efforts.
Key Features and Applications
The CRPN Quality Roadmap® is particularly well-suited for several applications, including:
- Quality Improvement Program Development: Establishing systematic processes for continuous improvement in quality management.
- Capital Projects Planning and Portfolio Analysis: Evaluating and prioritizing capital investments to ensure they align with compliance goals.
- Audit Response Plan Prioritization: Streamlining responses to audit findings by prioritizing issues based on their risk profiles.
- Compliance Risk Reduction Program Planning: Develop targeted programs to minimize compliance risks and enhance operational efficiencies.
- CAPA Risk, Remediation, and Resource Planning: Effectively managing Corrective and Preventive Actions (CAPA) to ensure timely resolution of compliance issues.
A Structured Methodology
The roadmap operates on a clear timeline of two to six months, consisting of several essential steps:
- Collect and Assess: In this initial phase, organizations gather data on issues, risks, gaps, and projects. This comprehensive assessment forms the foundation for further analysis.
- Risk Prioritization: Once the data is collected, the next step involves assessing the complexity of identified issues and prioritizing risks accordingly. This allows organizations to focus on the most pressing challenges first.
- Report Development: After prioritizing risks, companies prepare and communicate output reports. These reports offer stakeholders a clear view of risk landscapes and proposed remediation strategies.
- Operationalization: Organizations can optionally automate and operationalize their planning capabilities, integrating the roadmap into their ongoing compliance processes.
The Power of Algorithms
Risk Assessment
One of the CRPN Quality Roadmap® standout features is the calculation of the Compliance Risk Prioritization Number (CRPN). This metric quantifies compliance risk by assigning objective, weighted measures to multiple subjective compliance risk factors.
The formula considers various elements, including the size of gaps from cGMP, detectability, and FDA enforcement response. Organizations can ensure sufficient differentiation across their risk portfolio by normalizing relative risk on a scale of 0 to 100.
This algorithmic approach allows companies to prioritize risks and allocate resources more effectively and objectively. It helps transform qualitative risk information into quantitative data that can be used for compliance risk reporting and comparability purposes.
Complexity Evaluation
In addition to assessing risk, the CRPN Quality Roadmap® incorporates a Complexity Factor. This factor evaluates organizational complexity and cost by considering estimated remediation costs, the number of departments involved, the number of sites involved, and the time required to complete remediation activities. This comprehensive evaluation enables organizations to align their resource allocations with the complexity of each issue.
The Complexity Factor also assists in identifying “low-hanging fruit,” allowing organizations to target quick wins that can yield immediate improvements in compliance and quality.
Benefits of the CRPN Quality Roadmap®
The CRPN Quality Roadmap® offers a multitude of benefits, including:
- Alignment on Risk Considerations: The structured methodology provides a formal framework for quantifying FDA compliance enforcement risks, ensuring all stakeholders are aligned on critical risk factors.
- Data-Driven Planning: The user-friendly software tool enables regulated life-science manufacturers to develop quality and remediation plan documents based on objective data. This enhances capital and expense budgeting and project resource prioritization planning.
- Improved Executive Alignment: By clarifying risk and resource focus, the roadmap fosters greater alignment among executive stakeholders regarding strategic initiatives and remediation activities. This is especially important for driving organizational change and prioritizing quality objectives.
- Enhanced Resource Utilization: By clearly understanding risk rankings and remediation complexity, organizations can make informed decisions about resource utilization. This leads to more efficient project execution and better overall compliance management.
Check out the video below to learn how Bayer benefitted from our CRPN Quality Roadmap®.
Conclusion
The CRPN Quality Roadmap® is more than just a compliance tool; it’s a strategic ally for life-science manufacturers navigating the complexities of regulatory environments. Combining innovative methodology with cloud-based capabilities quantifies risks and provides a pragmatic framework for remediation planning.
As the life-science sector evolves, the CRPN Quality Roadmap® is a vital resource for companies committed to achieving operational excellence and compliance. It helps organizations manage compliance effectively and fosters a culture of continuous improvement in quality management.
For organizations looking to enhance their compliance strategies, the CRPN Quality Roadmap® offers a clear path forward, defined by structured analysis, risk prioritization, and a collaborative approach to quality management.
With its ability to improve stakeholder alignment and resource allocation, this roadmap is essential for any regulated life-science manufacturer aiming to thrive in a competitive landscape.
Contact Us
To learn more about CRPN Quality Roadmap®, contact us by filling out the form below.
What is CRPN Quality Roadmap®?
The CRPN Quality Roadmap® is a bespoke tool developed by Compliance Architects® that combines a defined methodology, proprietary risk and complexity algorithms, and cloud-based software to help life-science manufacturers prioritize compliance risks and develop effective quality improvement plans.
Who can benefit from CRPN Quality Roadmap®?
It is designed for organizations in the Pharma, BioPharma, and Medical Device sectors that must enhance their compliance strategies and quality management processes.
What challenges does the CRPN Quality Roadmap® address?
The roadmap helps organizations objectively prioritize thousands of Corrective and Preventive Actions (CAPAs) and manage compliance risks effectively, addressing issues like resource allocation and strategic planning.
How does the CRPN Quality Roadmap® work?
The process involves several steps:
Collect and Assess: Gathering data on risks, gaps, and projects.
Risk Prioritization: Assessing the complexity of issues and prioritizing risks.
Report Development: Preparing and communicating output reports.
Operationalization: Optionally automating planning capabilities.
What are the benefits of using the CRPN Quality Roadmap®?
Key benefits include:
– Alignment of risk considerations among stakeholders.
– Data-driven quality and remediation planning.
– Improved executive alignment on strategic initiatives.
– Enhanced resource utilization and project execution.
How long does the CRPN Quality Roadmap® process take?
The roadmap operates on a clear timeline of two to six months, depending on the organization’s needs and complexity.
Where can I learn more about the CRPN Quality Roadmap®?
For more information, contact Compliance Architects® through the contact form provided in the article or watch the linked videos for insights from other organizations that have benefited from the roadmap. See our page for the CRPN Quality Roadmap® here.
Can you provide examples of applications for the CRPN Quality Roadmap®?
Please see our Bayer Case Study to learn how our CRPN Quality Roadmap® benefitted their business. Click here for the Case Study.
